Hemorrhagic Complications of Transvaginal Oocyte's Retrieval: an Update.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 13,193
- Primary Endpoint
- Hemoperitoneum after oocyte transvaginal retrieval
Study Overview
Brief Summary
The goal of this retrospective analysis is to focus on peritoneal bleeding after oocyte retrieval and to further investigate factors related to this specific complication and if hemorrhagic complication rate modifications can be observed.
Detailed Description
The main aim is to update our knowledge on oocyte retrieval complication, focusing specifically on hemorrhagic / hemoperitoneum rate.
All retrievals will be retrieved in IVF/ICSI cycles and Fertility Preservation both in oncological patients and in patients requesting oocyte storage for deferring motherhood.
Data collection goes from January 2017 to December 2022.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to 45 Years (Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •patients that underwent a procedure of oocyte transvaginal retrieval for IVF/ intracytoplasmatic sperm injection (ICSI) cycles and fertility preservation
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Hemoperitoneum after oocyte transvaginal retrieval
Time Frame: Oocyte retrievals in the period January 2017- December 2022
number of patients with onset of hemoperitoneum
Secondary Outcomes
- Operator of the procedure(6 years)
- Time of symptoms onset(6 years)
- Loss of blood during procedure(6 years)
- Need for hospitalization(6 years)
- Incidence compared to past case history(6 years)
- Hemoglobin level before and after procedure(6 years)